Results 191 to 200 of about 303,943 (292)

Impact of Chronic Kidney Disease on Clinical, Laboratory, and Echocardiographic Features in Patients with Chronic Heart Failure. [PDF]

Diseases
Ilić A, Kovačević O, Milovančev A, Mladenović N, Andrić D, Dabović D, Jaraković M, Maletin S, Pantić T, Crnomarković B, Preveden M, Zdravković R, Stojšić Milosavljević A, Ilić A, Velicki L, Preveden A.   +15 more
europepmc   +1 more source

Epigenetic Regulation in the Pathogenesis of Renal Inflammation: Insights and Therapeutic Potentials

iNew Medicine, EarlyView.
ABSTRACT Renal inflammation is a common pathological process in various kidney diseases, often initiated by factors such as toxins, ischemia, or autoimmune reactions. This inflammatory response can result in structural damage and a rapid decline in renal function.
Yu‐Hang Dong, Xiao‐Yu Shen, Han‐Cheng Jin, Xiang‐Yu Li, Hao He, Xiao‐Ming Meng   +5 more
wiley   +1 more source

Benefits of SGLT2 inhibitors in patients with diabetes and advanced chronic kidney disease - where have we gone so far? [PDF]

Front Clin Diabetes Healthc
Duni A, Tsavourelou P, Triantafyllidou M, Gkika L, Georgopoulos C, Stamellou E, Kitsos A, Dounousi E.   +7 more
europepmc   +1 more source

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source

Guidance for umbrella reviews of observational studies: A scoping review

JCPP Advances, EarlyView.
This review examined existing guidance on conducting and reporting umbrella reviews of observational studies on epidemiological associations, aiming to help develop a formal reporting guideline. The search identified 4491 records, with eight documents providing limited guidance across seven topic areas.
Carl Zhou, Nicholas Fabiano, Arnav Gupta, Stanley Wong, Kelly D. Cobey, David Moher, Sanam Ebrahimzadeh, Jeremy Y. Ng, Elena Dragioti, Jae Il Shin, Joaquim Radua, Samuele Cortese, Beverley Shea, Nicola Veronese, Lisa Hartling, Michelle Pollock, Stefania Papatheodorou, John P. A. Ioannidis, Marco Solmi   +18 more
wiley   +1 more source

Riboflavin intake and kidney health: population evidence and mechanistic insights from NHANES and molecular docking analyses. [PDF]

Ren Fail
Wu P, Long W, Xiao X, Wang L, Xu Y, Ma X.   +5 more
europepmc   +1 more source

Response to the Nephrological perspectives on the underutilization of SGLT2i in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1492-1493, April 2025.
Umut Kocabas
wiley   +1 more source

Risk factors for carnitine deficiency in critically ill adults: A descriptive cross‐sectional study

Journal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Critical illness is a risk factor for carnitine deficiency. Carnitine deficiency may result in serious medical complications and poor clinical outcomes. This study aimed to identify the prevalence and potential predictors of carnitine deficiency.
Jennifer Gordon, Rebecca Brody, Hamed Samavat, Mireille Hamdan, Alexander L. Colonna, Jason B. Young, Laura D. Byham‐Gray   +6 more
wiley   +1 more source

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source